PAUL TAPIA: Open Payments
NPI 1740507177 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 29 payments from 13 companies in 2025. Trend: 2023 $1,461 · 2024 $1,255 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $772 |
| Regeneron Healthcare Solutions, Inc. | 3 | $171 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $154 |
| Stryker Corporation | 1 | $145 |
| Viatris Specialty LLC | 1 | $125 |
| Medtronic, Inc. | 1 | $123 |
| GENZYME CORPORATION | 2 | $65 |
| Genentech USA, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: TEZSPIRE, DUPIXENT, NEFFY, FLOWTRIEVER, YUPELRI, AURORA EV-ICD MRI SURESCAN, AIRSUPRA, LOKELMA.
Industry payments across NM — which companies pay providers there.
